Platelet-derived endothelial cell growth factor and lung cancer
Author Information
Author(s): Ml Koukourakis, A Giatromanolaki, KJ O'Byrne, M Comley, RM Whitehouse, DC Talbot, KC Gatter, AL Harris
Primary Institution: Imperial Cancer Research Fund Medical Oncology Unit; Department of Radiotherapy and Oncology, University Hospital of Iraklion; Department of Cellular Science, Oxford Radcliffe Hospital
Hypothesis
Does PD-ECGF/TP expression correlate with tumor angiogenesis and prognosis in non-small-cell lung cancer?
Conclusion
High expression of PD-ECGF/TP in non-small-cell lung cancer cells is associated with a more aggressive tumor phenotype and poorer prognosis, particularly in node-negative cases.
Supporting Evidence
- 25% of cases showed high PD-ECGF/TP expression associated with high vascular grade.
- 44% of high vascular grade tumors had positive PD-ECGF/TP reactivity.
- Positive PD-ECGF/TP expression was more frequent in T2-staged cases.
Takeaway
This study found that a protein called PD-ECGF/TP is linked to how blood vessels grow in lung cancer, which can affect how serious the cancer is.
Methodology
Immunohistochemical evaluation of PD-ECGF/TP expression in surgically resected specimens from 107 patients with operable non-small-cell lung cancer.
Limitations
The study did not find a significant correlation between PD-ECGF/TP expression and overall survival in all patients.
Participant Demographics
107 patients with operable non-small-cell lung cancer, including 65% squamous cell carcinomas and 35% adenocarcinomas.
Statistical Information
P-Value
0.04
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website